ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Alabama » General Practice

Top General Practice Prescribers in Alabama

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
WILLIAM HOBBS M.D.

General Practice

238

$27.3K

14
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 27%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

41%
prescriptions for brand name drugs

Avg: 22%

$115
Average prescription price

Avg: $51

CHARLES YEAGER MD

General Practice

186

$8,890

41
21 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

27%
patients receiving schedule three controlled substances

Avg: 27%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 22%

$48
Average prescription price

Avg: $51

RUTH SHIELDS MD

General Practice

739

$30.7K

51
22 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

29%
patients receiving schedule three controlled substances

Avg: 27%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 22%

$42
Average prescription price

Avg: $51

TREY LOTT MD

General Practice

147

$2,150

57
37 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

40%
patients receiving schedule three controlled substances

Avg: 27%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

12%
prescriptions for brand name drugs

Avg: 22%

$15
Average prescription price

Avg: $51

MATTHEW PARKER M.D.

General Practice

527

$39.7K

69
23 are 65+

29%
patients receiving schedule two controlled substances

Avg: 7%

41%
patients receiving schedule three controlled substances

Avg: 27%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 22%

$75
Average prescription price

Avg: $51

REBECCA HICKS M.D.

General Practice

2,530

$157K

80
21 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 27%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 22%

$62
Average prescription price

Avg: $51

JAY RIPKA M.D.

General Practice

1,725

$77.8K

108
27 are 65+

17%
patients receiving schedule two controlled substances

Avg: 7%

35%
patients receiving schedule three controlled substances

Avg: 27%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 22%

$45
Average prescription price

Avg: $51

FRANCES BARTEL M.D.

General Practice

3,222

$169K

111
52 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

25%
patients receiving schedule three controlled substances

Avg: 27%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 22%

$53
Average prescription price

Avg: $51

BOBBY MERKLE MD

General Practice

2,798

$103K

117
84 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 27%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 22%

$37
Average prescription price

Avg: $51

JANIE TESCHNER M.D.

General Practice

2,610

$122K

122
16 are 65+

18%
patients receiving schedule two controlled substances

Avg: 7%

49%
patients receiving schedule three controlled substances

Avg: 27%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 22%

$47
Average prescription price

Avg: $51

CHARLES BUCKMASTER M.D.

General Practice

2,273

$137K

128
43 are 65+

39%
patients receiving schedule two controlled substances

Avg: 7%

22%
patients receiving schedule three controlled substances

Avg: 27%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 22%

$60
Average prescription price

Avg: $51

COREY GILLILAND D.O.

General Practice

1,708

$79.3K

135
102 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 27%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 22%

$46
Average prescription price

Avg: $51

FRANK TOMBRELLO D.O.

General Practice

1,901

$59.4K

155
71 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

46%
patients receiving schedule three controlled substances

Avg: 27%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

12%
prescriptions for brand name drugs

Avg: 22%

$31
Average prescription price

Avg: $51

ANTHONY LESSA MD

General Practice

734

$26.1K

161
68 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

32%
patients receiving schedule three controlled substances

Avg: 27%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 22%

$36
Average prescription price

Avg: $51

MUKESHKUMAR PATEL MD

General Practice

3,361

$168K

176
117 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

23%
patients receiving schedule three controlled substances

Avg: 27%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $51

RICHARD STEHL MD

General Practice

4,480

$218K

190
95 are 65+

17%
patients receiving schedule two controlled substances

Avg: 7%

23%
patients receiving schedule three controlled substances

Avg: 27%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $51

BILL YATES MD

General Practice

4,798

$172K

191
117 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

40%
patients receiving schedule three controlled substances

Avg: 27%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 22%

$36
Average prescription price

Avg: $51

STEPHEN CHROMIAK MD

General Practice

1,426

$38.6K

204
124 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

27%
patients receiving schedule three controlled substances

Avg: 27%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

10%
prescriptions for brand name drugs

Avg: 22%

$27
Average prescription price

Avg: $51

JAMES DIXON DO

General Practice

5,048

$184K

230
124 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

40%
patients receiving schedule three controlled substances

Avg: 27%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 22%

$36
Average prescription price

Avg: $51

JERRY HANKINS MD

General Practice

906

$54.9K

233
158 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 27%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 22%

$61
Average prescription price

Avg: $51

MICHELE JORDAN M.D

General Practice

7,067

$330K

261
163 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

26%
patients receiving schedule three controlled substances

Avg: 27%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 22%

$47
Average prescription price

Avg: $51

MARK PITA M.D.

General Practice

3,025

$128K

279
106 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 27%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 22%

$42
Average prescription price

Avg: $51

ROBERT THEAKSTON M.D.

General Practice

3,992

$152K

294
177 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

31%
patients receiving schedule three controlled substances

Avg: 27%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 22%

$38
Average prescription price

Avg: $51

ASHLEY MCINTYRE MD

General Practice

12,067

$618K

329
208 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

26%
patients receiving schedule three controlled substances

Avg: 27%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $51

ROBERT BARTEL MD

General Practice

9,565

$602K

331
138 are 65+

16%
patients receiving schedule two controlled substances

Avg: 7%

46%
patients receiving schedule three controlled substances

Avg: 27%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 22%

$63
Average prescription price

Avg: $51

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank